Your Location：
Home >
Browse articles >
National mortality burden attributable to the unprecedented heatwave in 2022 in China
RESEARCH | Updated：2026-08-20
Previous|Next

    • National mortality burden attributable to the unprecedented heatwave in 2022 in China

    • Jian-Xiong Hu , Yu-Lin Zhuo , Guan-Hao He , Jiang-Mei Liu , Yan-Fang Guo , Tian-Tian Li , Wei-Wei Gong , Fang-Fang Zeng , Hai-Lai Duan , Rui-Lin Meng , Chun-Liang Zhou , Yi-Ze Xiao , Min Yu , Biao Huang , Mai-Geng Zhou , Wen-Jun Ma , Tao Liu
    • Military Medical Research Vol. 13, Issue 6, Pages: 929-943(2026)

    • DOI： 10.1186/s40779-025-00676-2     

      CLC：

    • Accepted：20 November 2025 ，

    Scan QR Code

  •  
  •  

  • Full Text(HTML)

  • Figs( 1 ) Tabs( 5 )

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

36

Views

53

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Burden of antimicrobial resistance in the WHO Southeast Asia and Western Pacific Regions, 1990–2021: a cross-country systematic analysis with forecasts to 2050
Risk factor control in relation to mortality and life expectancy among people with type 2 diabetes: results from 3 nationwide cohort studies
Associations of different definitions of prediabetes and diabetes with all-cause and cause-specific mortality: a nationally representative cohort study
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation

Related Author

Shao-Yu Liu
Shao-Kang Xu
Jing-Li Gao
Xiao-Ke Kong
Jian Shi
Ya Miao
Yi-Ting Tang
Bin Zhao

Related Institution

Department of Critical Care Medicine and Hematology, the Second Xiangya Hospital, Central South University
Department of Critical Care Medicine and Hematology, the Third Xiangya Hospital, Central South University
Department of Intensive Medicine, Kailuan General Hospital
National Clinical Research Center for Endocrine and Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University
CSU-Sinocare Research Center for Nutrition and Metabolic Health, Xiangya School of Public Health, Central South University; Furong Laboratory